Compare ARK Genomic Revolution ETF (ARKG) vs Gap Inc (GAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Gap Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Gap Inc trades at $19.41 (market cap $7.01B). The key difference: Gap Inc pays a 3.6% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Gap Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | GAP | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $29.13 |
52-Week Low | $23.09 | $18.35 |
Market Cap | — | $7.01B |
Enterprise Value | — | $10.09B |
Dividend Yield | — | 3.6% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Gap Inc. (GAP) trades at $19.46, up 3.24% today, with a bearish technical outlook but attractive valuation metrics including a P/E of 7.72 and P/S of 0.48. Recent earnings show mixed results with a Q1 2026 beat but a Q4 2025 miss. The company demonstrates strong profitability with a net income margin of 6.25% and ROE of 27.58%, supported by positive operating cash flow of $1.49 billion in 2025. News highlights include ongoing investigations by law firms and digital transformation efforts.
The stock presents a value opportunity with a consensus price target of $27.00, implying significant upside, but faces risks from legal scrutiny and competitive pressures. Analyst sentiment is mixed with 39.58% buy ratings, while technical indicators suggest near-term weakness. Revenue growth remains modest, projected at $15.4 billion for 2026, with earnings stability key to unlocking value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Gap Inc
Gap retails apparel, accessories, and personal-care products under the Gap, Old Navy, Banana Republic, and Athleta brands. Old Navy generates more than half of Gap's sales. The firm also operates e-commerce sites, outlet stores, and specialty stores under various Gap names. Gap operates nearly 3,000 stores in North America, Europe, and Asia and franchises about 600 stores in Asia, Europe, Latin America, and other regions. Gap was founded in 1969 and is based in San Francisco.
Read more on GAP →
